bisbenzimidazole has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We carried out the in vitro study using selective COX-2 inhibitor celecoxib combined with EGFR-tyrosine kinase inhibitor (EGFR-TKI) ZD1839 on NSCLC cell lines to investigate the anti proliferation effect and the cell molecular mechanism." | 1.35 | Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study. ( Chen, L; He, Y; Huang, H; Liao, H; Wei, W, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X | 1 |
| Ye, T | 1 |
| Liu, C | 1 |
| Lu, W | 1 |
| Lu, M | 1 |
| Zhang, J | 1 |
| Wang, M | 1 |
| Cao, P | 1 |
| Lobachevsky, P | 1 |
| Smith, J | 1 |
| Denoyer, D | 1 |
| Skene, C | 1 |
| White, J | 1 |
| Flynn, BL | 1 |
| Kerr, DJ | 1 |
| Hicks, RJ | 1 |
| Martin, RF | 1 |
| Chen, L | 1 |
| He, Y | 1 |
| Huang, H | 1 |
| Liao, H | 1 |
| Wei, W | 1 |
3 other studies available for bisbenzimidazole and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Bisbenzimidazole; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kin | 2011 |
Tumour targeting of Auger emitters using DNA ligands conjugated to octreotate.
Topics: Animals; Binding, Competitive; Biological Transport; Bisbenzimidazole; Carcinoma, Non-Small-Cell Lun | 2012 |
Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bisbenzimidazole; Blotting, Western; Carcinoma, Non- | 2008 |